Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA’s RTOR Program Produces Approvals About One Month Sooner Than Priority Review Goal
Aug 05 2022
•
By
Bridget Silverman
• Source: Nielsen Hobbs; the Pink Sheet | Shutterstock, Getty images
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from US FDA Performance Tracker
More from Regulatory Trackers